12th Global Pharma Conference & Expo
Download Brochure

Track 9: COVID-19 Impact on World-Wide Pharma Sector

Impact of Covid-19 

The World Health Organization (WHO) designated this SARS-CoV-2 illness as a new coronavirus disease in December 2019 and labelled it a global pandemic (COVID-19). Over 150 million people worldwide have been infected by COVID-19, which has resulted in over 3 lakh fatalities. The COVID-19 outbreak has had a significant negative impact on the healthcare business and has badly impacted the entire supply chain, from raw materials to manufacturing and distribution. The global demand for medical ventilators has compelled manufacturers to increase supply by up to 40–50%. Producers have partnered with automakers to help fulfil the rising demand. Along with other professionals in the business, governments and numerous organisations are heavily involved in addressing the global crisis. Leading individuals are engaged in research and development activities, strategic alliances and collaborations, and creative product releases in order to meet consumer demands for pharmaceuticals, vaccines, diagnostics, and medical equipment such as ventilators.

11th Global Pharma Conference and expo

COVID-19's Effect on Companies

Prior to COVID-19, the effect on ongoing research was quick, powerful, and lasting. Most basic science and clinical study-related research in academia, industry, and government was stopped or diverted to COVID-19 as a result of the pandemic. The pandemic scenario made it clear how important research, a strong research infrastructure, and financing are to PHE/disaster preparedness, response, and resilience. In a short period of time, COVID-19 has emerged as a global emergency with far-reaching consequences. Finding and analysing the academic research areas that will be impacted by COVID-19 is urgently needed. The following graphic shows the main fields of study that COVID-19 has an impact on.

Development of Vaccines

The creation of different antibodies that offer protection against COVID-19. Several research institutions and pharmaceutical firms have created vaccines with a strong efficacy profile, including Covaxin, Covishield, and Sputnik V.

Present-day Drug Development

According to several anecdotal case series and in vitro studies, hydroxychloroquine and azithromycin are both useful in the prevention and treatment of the disease. Clinical trials for the treatment of COVID-19 are now being conducted using several antiretroviral medications (used to treat HIV).

Many immunomodulatory herbs, including kalmegh and ashwagandha, and their constituents have been demonstrated to have positive benefits in the development of herbal drugs by preventing the interaction of the related proteins implicated in COVID-19 infection. A remedy called "Coronil" was created by Patanjali Ayurved Ltd. and may be useful in the fight against COVID-19. As a result, the growth of the herbal industry may result in great success for both pharmaceutical businesses and Indian traditional medical systems like Ayurveda.



For advanced manufacturing and advanced technologies, it is the fourth industrial revolution. It has the ability to track and analyse COVID-19 patients automatically. In addition to digital record keeping and analysis of health care management, it may also contain artificial intelligence-based technology to identify patients' data and geo-fence proper tracking.

Healthcare and Equipment Medical equipment such as surgical masks, protective clothing, sanitizers, ventilators, etc. are the subject of ongoing research. Protective apparel that complies with the necessary medical requirements is required, such as PPE kits.

Our Speakers For 11th Global 
Pharma Conference and Expo

Thus, it can be said that despite COVID-19's lethal effects, the healthcare system, pharmaceutical industry, and research have greatly benefited in India and around the world.